Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Nov 24.
Published in final edited form as: J Neuroendocrinol. 2020 Sep 29;32(11):e12905. doi: 10.1111/jne.12905

Transcriptional regulation of prolactin in a euryhaline teleost: Characterisation of gene promoters through in silico and transcriptome analyses

Andre P Seale 1, Gardi Hewage Tharindu Malintha 1, Fritzie T Celino-Brady 1, Tony Head 1, Mahdi Belcaid 2, Yoko Yamaguchi 3, Darren T Lerner 4, David A Baltzegar 5, Russell J Borski 6, Zoia R Stoytcheva 1, Jason P Breves 7
PMCID: PMC8612711  NIHMSID: NIHMS1753982  PMID: 32996203

Abstract

The sensitivity of prolactin (Prl) cells of the Mozambique tilapia (Oreochromis mossambicus) pituitary to variations in extracellular osmolality enables investigations into how osmoreception underlies patterns of hormone secretion. Through the actions of their main secretory products, Prl cells play a key role in supporting hydromineral balance of fishes by controlling the major osmoregulatory organs (ie, gill, intestine and kidney). The release of Prl from isolated cells of the rostral pars distalis (RPD) occurs in direct response to physiologically relevant reductions in extracellular osmolality. Although the particular signal transduction pathways that link osmotic conditions to Prl secretion have been identified, the processes that underlie hyposmotic induction of prl gene expression remain unknown. In this short review, we describe two distinct tilapia gene loci that encode Prl177 and Prl188. From our in silico analyses of prl177 and prl188 promoter regions (approximately 1000 bp) and a transcriptome analysis of RPDs from fresh water (FW)- and seawater (SW)-acclimated tilapia, we propose a working model for how multiple transcription factors link osmoreceptive processes with adaptive patterns of prl177 and prl188 gene expression. We confirmed via RNA-sequencing and a quantitative polymerase chain reaction that multiple transcription factors emerging as predicted regulators of prl gene expression are expressed in the RPD of tilapia. In particular, gene transcripts encoding pou1f1, stat3, creb3l1, pbxip1a and stat1a were highly expressed; creb3l1, pbxip1a and stat1a were elevated in fish acclimated to SW vs FW. Combined, our in silico and transcriptome analyses set a path for resolving how adaptive patterns of Prl secretion are achieved via the integration of osmoreceptive processes with the control of prl gene transcription.

Keywords: in silico, osmoreception, prolactin, promoter, salinity, tilapia, transcription factor, transcriptome

1 |. INTRODUCTION

Prolactin (Prl) is a pleiotropic hormone released from the pituitary gland that exhibits more biological activities within vertebrates than any other pituitary factor.1,2 Subsequent to its discovery in the 1930s, Prl has been linked with an array of physiological processes that support reproduction, osmoregulation, growth and development. In turn, decades of sustained investigation have focused upon how the release of Prl from the anterior pituitary is controlled.25 Across vertebrates, it is well established that a suite of hormones originating from central and peripheral sources participates in the complex regulation of Prl secretion.2,6 In addition to hormones with stimulatory or inhibitory activities, the extracellular osmotic environment is an important regulator of Prl cells in euryhaline teleost fishes.69 This “osmosensitive” mode of regulation underlies the key role that Prl plays in coordinating teleost osmoregulatory systems.1012

Hydromineral balance in vertebrates, including teleost fishes, is contingent upon the tight control of solute and water movements at the macromolecular, cellular and organismal levels. Fishes that inhabit tide-pools, rivers and estuaries are readily subjected to changes in salinity that threaten hydromineral balance. When exposed to abrupt changes in environmental salinity, complex homeostatic control systems operate to maintain internal osmotic conditions near established set-points (270–400 mOsm kg−1).13 Deviations from extracellular osmotic set-points are detected by osmosensitive cells, denoted “osmoreceptors”, which secrete hormones acting through systemic circulation to regulate organs (e.g. gill, kidney, intestine, urinary bladder and skin) that actively transport solutes and water.1419 For more than 40 years, Prl-secreting cells isolated from the rostral pars distalis (RPD) of Mozambique tilapia (Oreochromis mossambicus) have been intensely studied to resolve how perturbations in hydromineral balance (deviations of extracellular osmolality within 5 mOsm kg−1) modulate the release of Prl in fashions that support a return to homeostasis.16,20,21 The native range of Mozambique tilapia includes habitats with variable salinities; thus, as a model system, tilapia Prl cells allow for links to be made between aspects of cellular osmoreception and a life-history strategy that imposes substantial osmoregulatory demands.2225

2 |. TILAPIA PROLACTIN CELL: A MODEL FOR INVESTIGATING THE TRANSDUCTION OF OSMOTIC STIMULI

Given that a stable internal osmotic environment is indispensable to molecular and cellular functions across vertebrates, the systems that mediate osmoreception are likely to be conserved throughout evolution. One sees this in both mammals and teleost fishes where stretch-regulated channels control the entry of Ca2+ into osmoreceptive cells.26 The operation of stretch-regulated channels apparently occurs whether an osmoreceptor is activated by a rise or fall in extracellular osmolality. A rise in osmolality, for example, is the primary stimulus by which osmoreceptive vasopressin-secreting neurones are activated in mammals; reduced cell volume leads to the generation of action potentials via stretch-inactivated cation channels.27 By contrast, tilapia Prl cells are stimulated by a fall in osmolality via stretch-activated cation channels that are activated following an increase in cell volume. Tilapia Prl cells are suppressed by an increase in osmolality. Together, these responses are consistent with Prl promoting survival in over-hydrating conditions such as freshwater (FW) habitats.

The tilapia Prl cell exhibits several attributes that provide distinct advantages for studying osmoreception. Tilapia Prl cells can be isolated as a primary culture and studied in vitro because they comprise > 99% of the RPD.28 Moreover, the tilapia Prl cell model allows for the simultaneous quantification of gene expression and hormone secretion with other key parameters linked with osmoreception, such as cell volume, intracellular [Ca2+] and cAMP levels.16 Both in vivo and in vitro, prl gene expression and Prl release from the tilapia pituitary are inversely related to extracellular osmolality.20,21,2932 Hyposmotically driven increases in cell volume, mediated by aquaporin 3 (Aqp3), are coupled with the rapid influx of Ca2+ through transient receptor potential vanilloid 4 (Trpv4) channels. The increase in intracellular [Ca2+] activates Prl secretion.3337 Moreover, cAMP also accumulates in Prl cells in response to reduced extracellular osmolality and is dependent on the entry of extracellular Ca2+.3841 Although some of the signalling events that occur in response to hyposmotic stimulation have been well characterised, other aspects of Prl cell physiology remain unclear, especially how extracellular osmotic conditions are linked with appropriate prl gene expression (Figure 1).

FIGURE 1.

FIGURE 1

Depicting the steps involved in the transduction of a hyposmotic stimulus into prolactin (Prl) release by the tilapia pituitary, modified from Seale et al.6 Prl cells of the rostral pars distalis (RPD) synthesise and release Prl177 and Prl188 in response to a fall in extracellular osmolality. Hyposmotic stimulation leads to an Aqp3-dependent increase in cell volume that triggers the entry of Ca2+ through stretch-activated Trpv4 channels. Although Ca2+ and cAMP secondary messengers mediate Prl release, it is unknown how these intracellular signals participate in the transcriptional regulation of prl177 and prl188

The tilapia pituitary secretes two Prls, Prl188 and Prl177 (previously referred to as Prl I and Prl II, respectively), which are encoded by separate genes and share 30%−40% protein homology with mammalian Prl.42,43 Although both Prl177 and Prl188 respond to reductions in extracellular osmolality and exert similar ion-retaining effects,42 their release is differentially osmosensitive.31 prl mRNA levels are also differentially osmosensitive, with more robust expression of prl188 relative to prl177 in response to the same hyposmotic stimulus.31 Interestingly, the salinity acclimation history of fish also influences the osmotic responsiveness of isolated Prl cells. The baseline expression of prl177 and prl188 mRNAs is 30-fold higher in Prl cells of fish acclimated to FW vs seawater (SW). Consequently, Prl cells from FW-acclimated fish are not as responsive to hyposmotic stimulation as Prl cells from SW-acclimated fish with regard to prl mRNA levels.32,44 We have described additional instances of the distinct regulation of prl177 and prl188 levels by extracellular osmolality, such as during autocrine stimulation45 and between O. mossambicus and its congener, Oreochromis niloticus, with a more narrow salinity tolerance.46 In the latter study, differences in responses of Prls and prls to extracellular osmolality between both species may be tied, at least in part, to the observed inter-specific difference in salinity tolerance.

Previous investigations uncovered additional osmosensitive genes in tilapia Prl cells such as aqp3 and trpv4.32,37 As described above, these two genes encode proteins essential to the pathway mediating hyposmotically-induced Prl release. Although aqp3 levels are higher in Prl cells of fish acclimated to FW vs SW,37 trpv4 is induced by hyperosmotic conditions.32 We reported that osmotic stress transcription factor 1 (ostf1) mRNA levels in Prl cells increased in response to hyperosmotic stimulation 31; however, the role of Ostf1 in osmoreception remains to be clarified.31,32,37,47,48 Prl177 and Prl188 exert their actions through two Prl receptors, denoted Prlr1 and Prlr2.49,50 The expression of both prlr mRNAs is also osmosensitive, both in the gill, a target of Prl signalling, and in the pituitary.31,51 For example, we observed that prlr2 expression is enhanced in Prl cells exposed to hyperosmotic conditions in vivo and in vitro.31 The two tilapia Prlrs activate divergent downstream targets upon ligand binding; expression of Prlr2, but not Prlr1, improves the tolerance of HEK293 cells to osmotic challenges.50 Importantly, Fiol et al 50 showed that the osmotic responsiveness of tilapia Prlr2 was retained when expressed in mammalian cells (HEK293). Thus, several osmosensitive genes expressed in tilapia Prl cells are up-regulated in response to hyperosmotic conditions.

3 |. IN SILICO AND IN VITRO IDENTIFICATION OF TRANSCRIPTIONAL REGULATORS

Many layers of control are involved in transcriptional regulation, including transcription factors (TFs52,53) that bind DNA at specific TF binding sites (TFBSs) to either activate or repress transcription. TFs may act alone, or synergistically, in coordinated fashions with other TFs situated in close proximity to form a TF-module (TFM54). The composition and organisation of TFBSs and other cis-regulatory elements within a gene promoter defines the gene promoter context, which may be present within the promoters of multiple genes. This context provides the major means by which gene transcription is regulated. On the other hand, different TFs may compete for the same binding site and act in fashions that are antagonistic to one another, ultimately initiating, repressing or modulating expression of the regulated gene. The interplay among TFs allows for fine-tuned responses to a wide array of intra- and extracellular stimuli. Bioinformatics allows for the characterisation of shared promoter structures to closely examine the regulatory characteristics of genes that respond to common stimuli. Accordingly, in silico promoter analyses are widely employed to reveal gene-regulatory networks that are co-regulated without a priori knowledge of their associations.5457 Then, RNA-sequencing (RNA-seq) and a quantitative polymerase chain reaction (qPCR) can be subsequently carried out to validate the expression of TFs predicted via in silico promoter analysis. In the case of tilapia RPDs, the expression of putative targets can then be compared under different physiological conditions (e.g. hypo- vs hyperosmotic extracellular conditions). In a broader sense, transcriptome analyses in teleost fishes continue to facilitate the identification of novel genes involved in osmoregulation.5863

In the mammalian kidney, a functional hyperosmotic cis-response element was identified in cells of the renal medulla exposed to dramatic changes in extracellular osmolality.64 This osmotic-response element (ORE), also called tonicity-responsive enhancer, regulates genes involved in the accumulation of compatible osmolytes (i.e. sorbitol, betaine and inositol) to mitigate hyperosmotic stress.65 Following the initial characterisation of an ORE in the aldose reductase gene, which supports the conversion of glucose to sorbitol in response to hyperosmotic stress, other ORE-containing sequences that regulate osmolyte accumulation/transport were subsequently identified. These sequences regulate the Na+/Cl coupled betaine transporter and Na+/myo-inositol cotransporter genes. These hyperosmotically-induced genes share homologous sequences in their OREs, which in turn allowed for the functional characterisation of a consensus mammalian ORE.66 In a cell line derived from Mozambique tilapia brain, osmolality/salinity-responsive elements were identified that mediate transcriptional responses to hyperosmotic stimuli.67 By contrast, less is known about the transcriptional regulation of vertebrate genes that are induced by hyposmotic conditions. Hence, a wider perspective on the molecular mechanisms that operate within osmoreceptive cells will be gained by characterising the promoter regions of genes that respond to hyposmotic stimuli.

4 |. TRANSCRIPTIONAL REGULATION OF PROLACTIN IN TILAPIA

Across vertebrates, prl genes are comprised of five exons and four introns.68 Unlike mammalian prl genes that are 10–12 kb long, the lengths of teleost prl genes vary between 2.6 and 3.7 kb; the tilapia prl188 gene spans ~ 3.7 kb.68,69 The varying prl gene lengths are solely attributed to differently sized introns. Early studies in mice identified two regulatory regions associated with pituitary prl expression that interact with pituitary-specific transcription factor 1 (Pit170). In fishes, sequences upstream of prl genes also possess Pit1 binding sites. Mutational analyses revealed that a Pit1 binding site most proximal to the transcriptional start site (TSS) was sufficient alone to confer submaximal transcription of the rainbow trout (Oncorhynchus mykiss) prl gene.71 DNase I footprinting experiments and electrophoretic mobility-shift assays identified three regulatory regions within the 5’-flanking region of the tilapia prl188 gene homologous to mammalian binding sites for Pit1.72 Accordingly, rat Pit1 specifically bound to Pit1 binding sites in the flanking region of the tilapia prl188 gene. The tilapia prl188 promoter includes two microsatellite regions consisting of CA/GT repeats found between the putative binding sites for Pit1.68 Naylor and Clark73 demonstrated that CA/GT repeats formed left-handed zDNA that repressed prl expression in rat. Moreover, zDNA regions within the tilapia prl188 promoter were associated with differences in prl188 expression in fish exposed to different salinities.74 Truncation analyses of the tilapia prl188 promoter in transient expression assays confirmed the functionality of the promoter in driving transcription and revealed three regulatory regions, two with stimulatory effects and one with an inhibitory effect.72 Collectively, these investigations suggest that regulatory regions responsible for pituitary prl expression are conserved from fishes to mammals, thereby suggesting that common transcription factors drive pituitary prl expression across vertebrate clades. To shed light into the molecular mechanisms underlying osmotic regulation of prl genes, we first identified sequences within the promoter regions of tilapia prl genes that may play a role in regulating transcription in response to hyposmotic stimulation through in silico analysis of putative TFs with predicted TFBSs and TFMs. We then identified genes encoding TFs within the RPDs of Mozambique tilapia and compared expression levels between fish acclimated to FW vs SW. The most highly expressed genes were validated by qPCR.

5 |. IN SILICO MODEL OF PROLACTIN REGULATION

First, in silico searches were performed to screen for putative regulatory elements within the apprximately 3.3-kb promoter regions of prl177 and prl188. Our analysis was guided by the previous identification of three DNase protection regions, −643 to −593, −160 to −111 and −73 to −46 bp, in tilapia Prl cells.72 We first extracted the putative regulatory elements for the prl177 and prl188 promoters and identified a suite of TFMs predicted to control the expression of both genes (Figure 2). We found that only the ~ 0.25 kb regions flanking the TSSs share similarity; this similarity reflects the use of general transcriptional machinery factors such as TATA binding protein factor and CCAAT-enhancer-binding proteins (CEBPs). We identified a putative noncoding RNA (ncRNA) that overlaps with the prl188 promoter (−1.866 to −1.985 kb). ncRNAs are known to play a role in silencing or modulating transcription by regulating the chromatin structure and by enhancing or suppressing TF binding.7577 Thus, ncRNA may affect the chromatin structure or interfere with the binding of TFs in the prl188 promoter. In the prl188 promoter, we identified putative erythroblast transformation specific (ETSF/ETSF) and CEBP/CEBP TFM sites at −1.9 to −1.935 kb, suggesting possible competition with the ncRNA for promoter binding. Further studies are needed to characterise how ncRNAs may interact with chromatin structure to modulate prl188 in response to changing salinities. We found that SORY/paired box (PAX) and activator protein 1 family (AP1F)/SMAD are TFMs common to both the prl177 and prl188 promoters (Figure 2). On the other hand, although CEBP, GATA and specifity protein 1 (SP1F) binding sites were found in both the prl177 and prl188 promoters, they were in different positions and/or distinctly associated with other TFs. Lastly, a melanocyte inducing transcription factor (MITF) binding site was unique to the prl177 promoter, while brain-derived neurotrophic factor (BRNF)/retinoic acid receptor (RXR) sites were unique to the prl188 promoter (Figure 2).

FIGURE 2.

FIGURE 2

Comparison between predicted transcription factor modules in prl177 (orange band) and prl188 (green band) promoter regions up to −1.3 kb. Transcription factor-modules (TFMs) represented by white boxes are unique to either prl177 or prl188; TFMs represented by grey ovals are common to both prl177 and prl188. TFMs predicted to bind to the (−) strand are indicated by blue text; TFMs predicted to bind to the (+) stand are indicated by red text. Numbers below the promoter regions depict approximate bp positions of putative TFMs and their respective binding sites relative to the transcriptional start site (TSS). Red arrows on each promoter indicate the TSS. TFMs shown in horizontal stacks compete for binding to the same region

We identified cAMP-response element-binding protein (CREB) binding sites at −2.9 kb and −1.8 kb, and a CEBP site at −1.7 kb, of the prl188 promoter fragment. The prediction that CREB regulates prl188 expression is particularly noteworthy given that cAMP and Ca2+ second messengers play key roles in mediating hyposmotically-induced Prl release.34,39 CREB is a TF that binds to highly conserved cAMP-response elements (CRE) formed by the sequence, 5’-TGACGTCA-3’, and is activated by phosphorylation from various kinases, including protein kinase A and Ca2+/calmodulin dependent protein kinases.78 Moreover, the −2.9-kb site is a potential contributor to the activation of prl188 because it falls within the region (−2.6 to −3.0 kb) previously found to induce transcription by 34%.68 We also found that predicted zDNA regions of the prl177 promoter were separated by 2.9 kb, whereas, in the prl188 promoter, the separation was only 0.54 kb and the number and orientation of the CA/GT repeats differed. Together, the differences in predicted promoter regulation between prl177 and prl188 apparently underlie observed differences in their mRNA expression patterns.30

We next focused our analysis on the proximal promoter region, between −1 and −860 bp, of prl188 because it contains a functional Pit1 binding site,68 three DNAse protection regions72 and two microsatellite regions.74 We identified putative TFMs that overlap with three DNase protection regions reported by Poncelet et al 72 and identified Pit1/octamer (Oct1) binding sites encompassed by region III (Figure 3). Moreover, the BRNF/RXR TFM overlaps with the Pit1/Oct1 binding sites, and both Brn and Pit1 factors share the POU (Pit-Oct-Unc) DNA binding domain, which consists of two highly conserved regions, the POU-specific domain and the POU homeodomain. The POU domain is derived from the names of three TFs with well-conserved homeodomains: Pit1; the octamer transcription factor proteins, Oct-1 and Oct-2; and the neural Unc-86 transcription factor originally identified in Caenorhabditis elegans.79,80 Brn factors (brain-specific homeobox/POU domain protein, also known as POU domain transcription factor) are the mammalian TFs most closely related to Unc-86 that were isolated after the original POU domain factors. Brn-3 factors, for example, are expressed in the pituitary where they play critical roles in the development and function of the nervous system.81,82 Brn factors also interact with oestrogen receptors to regulate gene transcription.83 Tilapia Prl cells respond to 17β-oestradiol (E2),84 which further potentiates the agonistic activities of other hormones, such as gonadotrophin-releasing hormone and prolactin-releasing peptide, on Prl release.85,86 All these TFs, however, cannot simultaneously occupy the same DNA sequence, hence we hypothesise that BRNF/RXR may repress prl188 transcription in the pituitary. RXR is a member of the steroid/thyroid hormone superfamily of nuclear receptors that bind a variety of ligands including agonists, antagonists and synergists of gene transcription. In the nucleus, RXR functions as a TF that binds to gene promoter regions by either forming a homo- or heterodimer with another nuclear receptor.87 Because BRNF/RXR may suppress prl transcription in tilapia, it may operate in Prl cells of tilapia acclimated to SW when Prl secretion is minimal.88 When extracellular osmolality decreases following the transfer of an animal from SW to FW,21 BRNF/RXR would ostensibly be released from the promoter and allow for binding of Pit1/Oct1 TFs, which in turn induce prl expression.

FIGURE 3.

FIGURE 3

DNA sequence and regulatory elements of the proximal prl188 promoter (−0.88 kb). Nucleotide positions are indicated above the sequence. Both DNA strands are shown for regions −1 to −220 and −551 to −660 bp; only the coding strand is shown for the remainder of the sequence. The transcriptional start site (TSS) is indicated by the red bent arrow; the first exon of the prl188 gene is highlighted in yellow and the translation start site is highlighted in green. The dark purple box marks the region (−1 to −40 bp) where general transcription factors (TFs) are predicted to bind. Previously identified DNase protection regions72 are indicated by grey boxes. The underlined red regions represent microsatellite repeat regions (zDNA). Coloured boxes indicate putative TF-modules (TFMs) and their respective binding sites. TFMs shown above and below the sequence are predicted for the (+) and (−) strands, respectively. The purple box from −142 to −151 bp represents the overlap of the predicted sites for SORY/PAX3 and ETSF/AP1F on the (−) strand. Additional TFMs are colour coded to indicate their corresponding binding sequences

In the DNase protection region II, we identified overlapping binding sites for SORY/PAX3 and ESTF/AP1 TFs. SORY is an abbreviation generated by Genomatix (see below) to denote the Sry and Hox7 TFs. The sex-determining sry gene is found on Y chromosomes leading to the development of male phenotypes.89 Hox genes form a subset of homeobox genes that direct embryonic development along the head to tail axis. A number of hormones, including E2, also regulate hox expression.90 In this promoter region, we hypothesise that SORY/PAX3 TFs repress the expression of prl188 in gonadal tissues to ensure tight regulation of its expression. The ETSF1/AP1 TFs are typically activators of gene transcription and may stimulate prl188 transcription in the tissues where the SORY/PAX3 TFs are not expressed. The region with the greatest number of TFBSs as predicted by in silico analyses was consistent with previous luciferase assays with the prl188 promoter where the highest activity was found at −0.55 kb followed by the −0.8 and −3.4-kb regions.72 At approximately 0.5 kb of the prl188 promoter region, we found putative binding sites for BRNF/RXR, ETSF/ETSF, OCT1/PIT1 and interferon regulatory factor family/AP1F. Furthermore, the microsatellite regions that encompass the DNase protection region (−643 to −593 bp) also affect prl188 transcription.74 Near the DNase region, closest to the TSS (~60 base pairs upstream), we also found the preβ-cell leukemia homeobox (PBXC)/pancreatic duodenal homeobox 1 (PDX1) TFM. Although PDX1, also known as insulin promoter factor 1, is a TF in the ParaHox gene cluster,91 further studies are required to assign putative roles to both PDX1 and PBXC for the regulation of prl188 transcription.

6 |. IN VITRO IDENTIFICATION OF TRANSCRIPTION FACTORS FROM PRL CELLS

To confirm the expression of transcripts encoding the TFs described above, and to assess their expression in response to environmental salinity, we then analysed the transcriptome of tilapia RPDs collected from animals acclimated to either FW or SW. Consistent with previous studies,31,32 the expression of prl188 was higher in fish acclimated to FW vs SW (1 460 057 and 705 155 counts per million, respectively). We specifically targeted transcripts corresponding to TFs identified by our in silico analysis, and of the 192 TFs identified within tilapia RPDs, 51% corresponded to TFs predicted to bind to prl177 and prl188 promoter regions. Conversely, all TFs predicted to bind the prl177 and prl188 promoter regions by our in silico approach were confirmed to be present in tilapia RPDs. Table 1 lists the TFs with highest copy number within each TF family predicted to bind prl promoter regions based on the in silico map shown in Figure 2. The vast majority (186 of 192) of TF transcripts identified had higher copy numbers in SW- vs FW-acclimated fish. Of the TFs also predicted to possess binding sites on the promoter regions of prl177 and prl188, only the myeloblastosis viral oncogene homolog 1 (mybl1) gene transcript was up-regulated in FW-acclimated fish (Table 1). In addition to Pit1 (pou1f1), CREB and signal transducer and activator of transcription (STAT) have also been implicated in the control of Prl cells (Table 1). Relative expression levels of pou1f1, stat3, creb3l1, pbxip1a and stat1a were assessed by qPCR (Figure 4). Although there were no differences in pou1f1 and stat3 expression in the RPDs of FW- vs SW-acclimated tilapia, patterns of elevated expression in SW fish were confirmed for creb3l1, pbxip1a and stat1a (Figure 4CE). CREB proteins that bind to the CRE region are typically activated by protein kinases elevated in response to cAMP and/or Ca2+. Although both of these second messengers play a role in hyposmotically-induced Prl release,39,41 they are also involved in the inhibition of Prl.92 It is worth noting that, although FW-acclimated tilapia exhibit higher prl mRNA levels than SW-acclimated counterparts, fish that are acclimated to SW induce a greater increase in prl gene expression in response to a hypoosmotic stimulus. The differing osmosensitivity based upon acclimation history may presumably occur because of the much lower mRNA levels of prl in SW44 and is corroborated by the observation that many of the TFs responsive to Ca2+ and cAMP, especially CREB, are up-regulated in SW. With greater expression in SW, multiple TFs apparently suppress prl genes. Inasmuch as the Janus kinase/STAT pathway is a known mediator of Prl signalling, the presence of two STAT isoforms among the genes with the highest copy numbers in the RPD transcriptome is consistent with the autocrine effects of Prl177 and Prl188 on tilapia Prl cells.45 Leptin similarly works through STAT signalling; this cytokine rises with SW acclimation and is a potent regulator of Prl release and gene expression and cellular glycolysis in tilapia.9396 From our previous studies,6 it is apparent that the regulation of Prl release is multi-faceted, with a large number of agonists and inhibitors adding complexity to the physiological regulation of this pleiotropic hormone. With the unveiling of both the in silico regulatory model and the in vitro transcriptome of TFs, it is increasingly evident that osmotic regulation of the prl gene is complex. Although the high number of TFs up-regulated in SW-acclimated fish may suggest that prls are under inhibitory control, further investigation on the regulation and function of the most predominant TFs is warranted. Further analyses are required to unravel the responses of TFs associated with the prl promoter to changes in salinity in vivo and the interactions of predicted TFs, TFMs and zDNA regions that underlie osmotic regulation of prl177 and prl188 expression and their dependency on cAMP and Ca2+ second messengers.

TABLE 1.

List of major transcription factor genes and related transcripts identified in the RPDs of FW- and SW-acclimated Mozambique tilapia

Accession number (NCBI or ZFIN) Copy number (CPM)
Gene Description TF family FW SW FC P FDR
NCBL100698135 pou1f1 POU class 1 homeobox 1 PIT1 2396.0 ± 614 3564.4 ± 376 1.5 0.194 0.397
NCBL100692602 stat3 signal transducer and activator of transcription 3 STAT 2154.8 ± 399 3776.5 ± 554 1.8 0.083 0.339
NCB 1:100703380 creb3l1 cAMP responsive element-binding protein 3 like 1 CREB 484.1 ± 39 851.5 ± 157 1.8 0.136 0.355
NCBL100709266 pbxip1a Pre-B-cell leukemia transcription factor-interacting protein 1 PBXC 453.5 ± 94 658.8 ± 58 1.5 0.152 0.358
NCBL100696359 stat1a Signal transducer and activator of transcription 1 STAT 440.1 ± 76 750.2 ± 116 1.7 0.100 0.340
NCB 1:100707472 ap2b1 AP-1 complex subunit beta-1 AP2F 408.6 ± 71 625.6 ± 92 1.5 0.140 0.355
ZFIN:ZDB-GENE-020111–3 cebpb CCAAT-enhancer binding protein beta CEBP 321.3 ± 76 486.7 ± 133 1.5 0.357 0.545
NCBL100706939 foxo1a Forkhead box protein O1-A FKHD 222.0 ± 42 487.7 ± 88 2.2 0.076 0.339
RefSeq:NM_001311335 foxp2 Oreochromis niloticus forkhead box P2 FKHD 200.8 ± 50 380.3 ± 77 1.9 0.133 0.355
NCBL100705959 ap1b1 Adaptor related protein complex 1 subunit beta 1 AP1F 188.1 ± 32 444.1 ± 87 2.4 0.085 0.339
NCBL100695946 irf2 Inferieron regulatory factor 2 IRF 155.0 ± 27 230.0 ± 15 1.5 0.092 0.340
ZFIN:ZDB-GENE-001031–1 pax6b Paired box 6b PAX6 148.0 ± 25 198.6 ± 31 1.3 0.280 0.460
NCBL100711701 stat4 Signal transducer and activator of transcription 4 STAT 145.3 ± 22 311.2 ± 44 2.1 0.046 0.339
NCBL100701775 crebzf CREB/ATF bZIP transcription factor CREB 141.3 ± 26 242.6 ± 6 1.7 0.054 0.339
NCBL100711301 nfatc1 Nuclear factor of activated T-cells, NFAT 139.7 ± 14 292.1 ± 66 2.1 0.143 0.355
NCBI:100701828 ebox Zinc finger E-box-binding homeobox 1 EBOX 109.3 ± 17 229.7 ± 16 2.1 0.006 0.244
ZFIN:ZDB-GENE-091111–4 nf1b Neurofibromin 1b NF1F 102.3 ± 16 236.0 ± 51 2.3 0.107 0.344
NCBI:100690945 stat5b Signal transducer and activator of transcription 5B STAT 78.0 ± 6 125.0 ± 15 1.6 0.076 0.339
NCBI:30486 rxrbb Retinoid x receptor, beta b RXRF 63.0 ± 16 104.3 ± 17 1.7 0.146 0.355
NCBI:100707575 brf1 BRF1 RNA polymerase III transcription initiation factor subunit BRNF 53.3 ± 10 101.7 ± 14 1.9 0.056 0.339
NCBI:100690316 sp1 Sp1 transcription factor SP1F 43.5 ± 7 79.4 ± 11 1.8 0.061 0.339
NCBI:100704116 smad9 SMAD family member 9 SMAD 31.8 ± 9 77.7 ± 15 2.4 0.072 0.339
NCBI:100707537 Sox5 SRY-box transcription factor 5 SORY 24.0 ± 7 54.7 ± 11 2.3 0.084 0.339
NCBI:100711278 ets1 ETS proto-oncogene 1, transcription factor ETSF 21.7 ± 4 40.3 ± 5 1.9 0.052 0.339
NCB 1:100705840 gata2a GATA-binding factor 2 GATA 14.7 ± 3 48.0 ± 17 3.3 0.177 0.390
NCBI:100699256 mitfb Microphthalmia-associated transcription factor MITF 12.7 ± 2 10.7 ± 2 0.8 0.554 0.695
ZFIN:ZDB-GENE-030131–2422 pou2f1b POU class 2 homeobox 1b OCT1 11.7 ± 3 26.3 ± 3 2.3 0.034 0.339
ZFIN:ZDB-GENE-041111–281 mybl1 v-myb avian myeloblastosis viral oncogene homolog-like 1 MYBL 2.3 ± 0 0.7 ± 1 0.3 0.113 0.346
NCBI:100699915 pdx1 Pancreatic and duodenal homeobox 1 PDX1 1.7 ± 1 2.7 ± 0 1.6 0.274 0.455

Abbreviations: FC, fold-change in SW relative to FW; FDR, false discovery rate; FW, copy number from freshwater-acclimated fish (mean ± SEM, n = 3); P, P value; SW, copy number from seawater-acclimated fish (mean ± SEM, n = 3); TF, transcription factor.

FIGURE 4.

FIGURE 4

Gene expression of pou1f1 (A), stat3 (B), creb3l1 (C), pbxip1a (D) and stat1a (E) in the rostral pars distalis (RPD) of Mozambique tilapia acclimated to fresh water (FW) (solid bars) and seawater (SW) (shaded bars). mRNA levels are presented as a fold-change from the FW group. Data are the mean ± SEM (n = 12). *P < 0.05, **P < 0.01 and ***P < 0.001 (Student’s t test)

In conclusion, the suite of TFs and their associated TFMs predicted through in silico analyses and confirmed by RNAseq/qPCR highlights the complex nature of prl transcriptional regulation. These analyses have only begun to unravel how differences between prl177 and prl188 expression are generated in response to a common hyposmotic stimulus. The contrasting regulation of tilapia prl177 vs prl188 reflects differences in how their hormone products mediate processes related to osmoregulation and growth.15,41 Although Prl188 is more robustly synthesised and released in response to a fall in extracellular osmolality compared with Prl177, the latter exerts somatotrophic activity.97 Ultimately, the regulatory mechanisms that underlie the transcription, translation, and secretion of both prls/Prls are fundamental to the capacity of euryhaline tilapia to thrive in a range of environmental salinities.

7 |. METHODS

7.1 |. Animals

Mature Mozambique tilapia of both sexes (ranging between 33–166 g for RNA-seq samples and 150–1200 g for qPCR) were reared in outdoor tanks with a continuous flow of either FW or SW under natural photoperiod. SW-acclimated tilapia employed in this experiment were spawned and reared in SW, having never been previously exposed to FW. FW-acclimated tilapia, on the other hand, were spawned and reared in FW, having never been previously exposed to SW. Water temperature was maintained at 24–26°C. Animals were fed approximately 5% of their body weight per day with Silver Cup Trout Chow (Nelson and Sons, Murray, UT, USA). All experiments were conducted in accordance with the principles and procedures approved by the Institutional Animal Care and Use Committee, University of Hawaii.

7.2 |. Bioinformatics

Among two PRL isoforms of O. mossambicus, only the sequence of prl188 gene, including the promoter region, was previously reported (X92380). In O. niloticus, the prl177 gene is located at LG4 (LOC100534523) and arrayed tandemly with the upstream prl188 gene (LOC100534522). To obtain the promoter sequence of O. mossambicus prl177, a genomic fragment (approximately 14.7 kb; prediction based on O. niloticus data) spanning between the O. mossambicus prl188 and prl177 genes was amplified using a pair of primers designed in the downstream region of the last exon of the O. mossambicus prl188 gene (X92380; forward) and in the first exon of the O. niloticus prl177 (NM_001279792; reverse) gene. The primers used were: (forward) cggtacccggggatccAAGACATAAAGACCTGGATGACTGACTGCT and (reverse) cgactctagaggatccTGAGTTTGCTTCCACTGATTCTTCTCTGAG, lower-case and capital letters represent nucleotides specific to the pUC19 vector and those specific to O. mossambicus (forward) or O. niloticus (reverse), respectively. Genomic DNA template was prepared from the liver of a female tilapia (32 g) by the salting-out method. Then, 100 mg of tissue was minced and digested overnight at 37°C in 2 mL of lysis buffer (0.5 mg mL−1 proteinase K, 10 mmol L−1 Tris-HCl, 10 mmol L−1 ethylenediaminetetraacetic acid, 100 mmol L−1 NaCl, 0.5% sodium dodecyl sulphate; pH 8.0). Then, the protein portion was precipitated and removed by adding 500 μL of 6 mol L−1 NaCl to a 1-mL aliquot of lysate. Genomic DNA was harvested by adding one volume of isopropanol to the supernatant. Next, 500 ng of DNA was subjected to PCR with PrimeSTAR GXL DNA Polymerase (Takara Bio, Mountain View, CA, USA) using the primers described above. The amplified genomic fragment was separated by agarose gel electrophoresis and purified using the UltraClean GelSpin DNA Extraction Kit (MO BIO Laboratories, Carlsbad, CA, USA). The purified fragment was cloned into the pUC19 vector using In-Fusion HD Cloning Plus (Takara Bio) prior to sequencing of the 3’ region. Sequencing was performed at the Advanced Studies in Genomics, Proteomics and Bioinformatics facility (ASGPB), University of Hawaii at Mānoa. The sequence of the O. mossambicus prl177 promoter (3.344 kb) is provided in the Supporting information (Figure S1). The approximately 3.4-kb promoters of O. niloticus and O. mossambicus prl177 share approximately 94% identity. The putative TFBSs, TFs and TFMs in the prl177 and prl188 promoter sequences were identified and mapped using the MATINSPECTOR and MODELINSPECTOR tools of the Genomatix Software Suite (MATRIX FAMILY LIBRARY, version 11.0 and MODULE LIBRARY, version 6.3; Genomatix, Munich, Germany). This software version contains binding site descriptions for 9968 transcription factors and 839 Homo sapiens, 818 Mus musculus, 618 Xenopus tropicalis and 612 Danio rerio weight matrices. The promoter module library used for the MODELINSPECTOR tool contained 919 regulatory modules.

7.3 |. RNA-seq and analyses of the RPD transcriptome

Fish residing in FW or SW (30 per salinity) were anaesthetised with 2-phenoxyethanol (0.3 mL L−1; Sigma, St. Louis, MO, USA). Fish were then killed by rapid decapitation, pituitaries extracted and the RPD dissected. The RPDs were pooled by acclimation salinity and then transferred to tubes containing 1 mL of Tri-Reagent (Molecular Research Center, Cincinnati, OH, USA) at 10 RPDs per tube (ie, three replicates per treatment). Total RNA was isolated from RPDs using Tri-Reagent coupled with on-column affinity purification, and DNase treatment (Direct-zol minipreps; Zymo Research Corporation, Irvine, CA) as described previously.95 RPD total RNA (10 μg) was submitted to North Carolina State University Genomic Sciences Laboratory (Raleigh, NC, USA) for mRNA enrichment, cDNA synthesis and Illumina library construction utilising a Truseq RNA library prep kit v1 (Illumina, San Diego, CA, USA) in conjunction with kit-provided oligo dt capture of mRNAs from sample total RNA. Illumina libraries (n = 3; see above) were prepared for each treatment (FW and SW). Sequencing was performed on an Illumina MiSeq platform at the Hawaii Institute of Marine Biology Genetics Core Facility with 100 × 2-bp paired-end protocol and with a mean cluster yield of 2.6 million paired reads per library (9.7 Gb total).

FASTQC98 and TRIMMOMATIC99 software were used as quality control tools to inspect the data and trim adapters or low quality reads. BOWTIE, version 1.0100 was used to map the reads to the O niloticus reference genome (OreNil 1.0 Broad Institute101). Then, RNA-seq by expectation-maximisation102 was used to quantify transcripts as counts per million (ie, copy number); EBseq103 was employed to analyse differential expression between the two treatments. The BIOMART tool104 was used to identify tilapia TF transcripts from the Nile tilapia genome (Ensembl; https://www.ensembl.org/index.html).

7.4 |. qPCR

RPDs were dissected out from 12 FW and 12 SW-reared tilapia. Total RNA was extracted using TRI Reagent in accordance with the manufacturer’s instructions. The concentration and purity of extracted RNA were assessed using a NanoDrop (NanoDrop One; Thermo Fisher Scientific, Waltham, MA, USA). Total RNA (400 ng) was reverse-transcribed using a High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). The mRNA levels of reference and target genes were determined by the relative quantification method using a StepOnePlus real-time PCR system (Thermo Fisher Scientific). The qPCR reaction mix (15 μL) contained Power SYBR Green PCR Master Mix (Thermo Fisher Scientific), 200 nmol L−1 forward and reverse primers and 1 μL of cDNA. Dilution of experimental cDNA from RPDs ranged from one- to 10-fold. PCR cycling parameters were: 2 min at 50°C, 10 min at 95°C followed by 40 cycles at 95°C for 15 seconds and 60°C for 1 minute. Gene specific primers were designed using PRIMER-BLAST (NCBI, Bethesda, MD, USA); non-specific product amplification and primer-dimer formation were assessed by melt curve analyses. Primer sequences, amplification efficiencies and amplicon sizes are provided in the Supporting information (Table S1). After verification that levels did not vary across treatments, 18S ribosomal RNA was used to normalise target genes. Data are expressed as a fold-change relative to the FW group. Group comparisons were performed by two-tailed Student’s t test. Data were log-transformed when necessary to meet assumptions of normality (assessed by Shapiro-Wilk test). Statistical calculations were performed using PRISM, version 8.0 (GraphPad Software Inc., San Diego, CA, USA). P < 0.05 was considered statistically significant.

Supplementary Material

Table S1
Figure S1

ACKNOWLEDGEMENTS

This work was funded in part by grants from the National Science Foundation (IOS-1755016, IOS-1755131 and IOS-1457040), the National Oceanic and Atmospheric Administration (NA18OAR4170347), the National Institute of Diabetes and Digestive and Kidney Diseases (1R21DK111775–01), the National Institute of Food and Agriculture (Hatch no. HAW02051-H), the Undergraduate Research Opportunities Program in the Office of the Vice-Chancellor for Research at the University of Hawai’i at Mānoa and by the Edwin W. Pauley Foundation. We are also grateful to the Genetics Core Facility at the Hawaii Institute of Marine Biology.

Funding information

National Science Foundation, Grant/Award Number: IOS-1755016, IOS-1755131 and IOS-1457040; National Oceanic and Atmospheric Administration, Grant/Award Number: NA18OAR4170347; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: 1R21DK111775–01; National Institute of Food and Agriculture, Grant/Award Number: HAW02051-H; Undergraduate Research Opportunities Program in the Office of the Vice-Chancellor for Research at the University of Hawai’i at Mānoa; Edwin W. Pauley Foundation

Footnotes

CONFLICT OF INTERESTS

The authors declare that they have no conflicts of interest.

SUPPORTING INFORMATION

Additional supporting information may be found online in the Supporting Information section.

DATA AVAILABILITY

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

  • 1.Bern HA, Nicoll CS. The comparative endocrinology of prolactin. Recent Prog Horm Res. 1968;24:681–720. [DOI] [PubMed] [Google Scholar]
  • 2.Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80:1523–1631. [DOI] [PubMed] [Google Scholar]
  • 3.Bernard V, Young J, Chanson P, Binart N. New insights in prolactin: pathological implications. Nat Rev Endocrinol. 2015;11:265–275. [DOI] [PubMed] [Google Scholar]
  • 4.Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrin Rev. 1998;19:225–268. [DOI] [PubMed] [Google Scholar]
  • 5.Phillipps HR, Yip SH, Grattan DR. Patterns of prolactin secretion. Mol Cell Endocrinol. 2020;502:110679. [DOI] [PubMed] [Google Scholar]
  • 6.Seale AP, Yamaguchi Y, Johnstone WM III, Borski RJ, Lerner DT, Grau EG. Endocrine regulation of prolactin cell function and modulation of osmoreception in the Mozambique tilapia. Gen Comp Endocrinol. 2013;192:191–203. [DOI] [PubMed] [Google Scholar]
  • 7.Sage M. Responses to osmotic stimuli of Xiphophorus prolactin cells in organ culture. Gen Comp Endocrinol. 1968;10:70–74. [DOI] [PubMed] [Google Scholar]
  • 8.Ingleton PM, Baker BI, Ball JN. Secretion of prolactin and growth hormone by teleost pituitaries in vitro: I. Effect of sodium concentration and osmotic pressure during short-term incubations. J Comp Physiol. 1973;78:317–328. [Google Scholar]
  • 9.Kwong AK, Ng AH, Leung LY, Man AK, Woo NY. Effect of extracellular osmolality and ionic levels on pituitary prolactin release in euryhaline silver sea bream (Sparus sarba). Gen Comp Endocrinol. 2009;160:67–75. [DOI] [PubMed] [Google Scholar]
  • 10.Hirano T. The spectrum of prolactin action in teleosts. In: Ralph CL, ed. Comparative Endocrinology: Developments and Directions. New York, NY: A. R. Liss; 1986:53–74. [PubMed] [Google Scholar]
  • 11.Manzon LA. The role of prolactin in fish osmoregulation: a review. Gen Comp Endocrinol. 2002;125:291–310. [DOI] [PubMed] [Google Scholar]
  • 12.Breves JP, McCormick SD, Karlstrom RO. Prolactin and teleost ionocytes: new insights into cellular and molecular targets of prolactin in vertebrate epithelia. Gen Comp Endocrinol. 2014;203:21–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Evans DH, Claiborne JB. Osmotic and ionic regulation in fishes. In: Evans DH, ed. Osmotic and Ionic Regulation: Cells and Animals. Boca Raton, FL: CRC Press; 2008:295–366. [Google Scholar]
  • 14.Fiol DF, Kultz D. Osmotic stress sensing and signaling in fishes. The FEBS J. 2007;274:5790–5798. [DOI] [PubMed] [Google Scholar]
  • 15.Inokuchi M, Breves JP, Moriyama S, et al. Prolactin 177, prolactin 188, and extracellular osmolality independently regulate the gene expression of ion transport effectors in gill of Mozambique tilapia. Am J Physiol. 2015;309:R1251–1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Seale AP, Hirano T, Grau EG. Osmoreception: a fish model for a fundamental sensory modality. In: Zaccone G, Reinecke M, Kapoor BK, eds. Fish Endocrinology. Enfield, NH: Science Publishers; 2006:419–440. [Google Scholar]
  • 17.Seale AP, Stagg JJ, Yamaguchi Y, et al. Effects of salinity and prolactin on gene transcript levels of ion transporters, ion pumps and prolactin receptors in Mozambique tilapia intestine. Gen Comp Endocrinol. 2014;206:146–154. [DOI] [PubMed] [Google Scholar]
  • 18.Bourque CW, Oliet SH. Osmoreceptors in the central nervous system. Annu Rev Physiol. 1997;59:601–619. [DOI] [PubMed] [Google Scholar]
  • 19.Breves JP, Watanabe S, Kaneko T, Hirano T, Grau EG. Prolactin restores branchial mitochondrion-rich cells expressing Na+/Cl cotransporter in hypophysectomized Mozambique tilapia. Am J Physiol. 2010;299:R702–R710. [DOI] [PubMed] [Google Scholar]
  • 20.Seale AP, Fiess JC, Hirano T, Cooke IM, Grau EG. Disparate release of prolactin and growth hormone from the tilapia pituitary in response to osmotic stimulation. Gen Comp Endocrinol. 2006;145:222–231. [DOI] [PubMed] [Google Scholar]
  • 21.Seale AP, Riley LG, Leedom TA, et al. Effects of environmental osmolality on release of prolactin, growth hormone and ACTH from the tilapia pituitary. Gen Comp Endocrinol. 2002;128:91–101. [DOI] [PubMed] [Google Scholar]
  • 22.Trewavas E. Tilapiine fishes of the genera Sarotherodon, Oreochromis and Danakilia. British Museum (Natural History) Publication number 878. Ithaca, NY: Cornell University Press; 1983. [Google Scholar]
  • 23.Moorman BP, Inokuchi M, Yamaguchi Y, Lerner DT, Grau EG, Seale AP. The osmoregulatory effects of rearing Mozambique tilapia in a tidally changing salinity. Gen Comp Endocrinol. 2014;207:94–102. [DOI] [PubMed] [Google Scholar]
  • 24.Seale AP, Pavlosky KK, Celino-Brady FT, Yamaguchi Y, Breves JP, Lerner DT. Systemic versus tissue-level prolactin signaling in a teleost during a tidal cycle. J Comp Physiol. 2019;189:581–594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pavlosky KK, Yamaguchi Y, Lerner DT, Seale AP. The effects of transfer from steady-state to tidally-changing salinities on plasma and branchial osmoregulatory variables in adult Mozambique tilapia. Comp Biochem Physiol. 2019;227:134–145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Seale AP, Hirano T, Grau EG. Stimulus-secretion coupling in the osmoreceptive prolactin cell of the tilapia. In: Kamkin A, Kiseleva I, eds. Mechanosensitivity of the Cells from Various Tissues. 1st ed. Moscow, Russia: Academia; 2005:371–389. [PubMed] [Google Scholar]
  • 27.Bourque CW. Osmoregulation of vasopressin neurons: a synergy of intrinsic and synaptic processes. Prog Brain Res. 1998;119:59–76. [DOI] [PubMed] [Google Scholar]
  • 28.Nishioka RS, Kelley KM, Bern HA. Control of prolactin and growth hormone secretion in teleost fishes. Zool Sci. 1988;5:267–280. [Google Scholar]
  • 29.Borski RJ, Hansen MU, Nishioka RS, Grau EG. Differential processing of the two prolactins of the tilapia (Oreochromis mossambicus), in relation to environmental salinity. J Exp Zool. 1992;264:46–54. [Google Scholar]
  • 30.Grau EG, Nishioka RS, Bern HA. Effects of osmotic pressure and calcium ion on prolactin release in vitro from the rostral pars distalis of the tilapia Sarotherodon mossambicus. Gen Comp Endocrinol. 1981;45:406–408. [DOI] [PubMed] [Google Scholar]
  • 31.Seale AP, Moorman BP, Stagg JJ, Breves JP, Lerner D, Grau G. Prolactin 177, prolactin 188 and prolactin receptor 2 in the pituitary of the euryhaline tilapia, Oreochromis mossambicus, are differentially osmosensitive. J Endocrinol. 2012;21:389–398. [DOI] [PubMed] [Google Scholar]
  • 32.Seale AP, Watanabe S, Breves JP, Lerner DT, Kaneko T, Gordon GE. Differential regulation of TRPV4 mRNA levels by acclimation salinity and extracellular osmolality in euryhaline tilapia. Gen Comp Endocrinol. 2012;178:123–130. [DOI] [PubMed] [Google Scholar]
  • 33.Weber GM, Seale AP, Richman IN, Stetson MH, Hirano T, Grau EG. Hormone release is tied to changes in cell size in the osmoreceptive prolactin cell of a euryhaline teleost fish, the tilapia, Oreochromis mossambicus. Gen Comp Endocrinol. 2004;138:8–13. [DOI] [PubMed] [Google Scholar]
  • 34.Seale AP, Richman NH, Hirano T, Cooke I, Grau EG. Cell volume increase and extracellular Ca2+ are needed for hyposmotically induced prolactin release in tilapia. Am J Physiol. 2003;23(284):C1280–C1289. [DOI] [PubMed] [Google Scholar]
  • 35.Seale AP, Richman NH, Hirano T, Cooke I, Grau EG. Evidence that signal transduction for osmoreception is mediated by stretch-activated ion channels in tilapia. Am J Physiol. 2003;23(284):C1290–C1296. [DOI] [PubMed] [Google Scholar]
  • 36.Watanabe S, Seale AP, Grau EG, Kaneko T. Stretch-activated cation channel TRPV4 mediates hyposmotically induced prolactin release from prolactin cells of mozambique tilapia Oreochromis mossambicus. Am J Physiol. 2012;302:R1004–R1011. [DOI] [PubMed] [Google Scholar]
  • 37.Watanabe S, Hirano T, Grau EG, Kaneko T. Osmosensitivity of prolactin cells is enhanced by the water channel aquaporin-3 in a euryhaline Mozambique tilapia (Oreochromis mossambicus). Am J Physiol. 2009;296:R446–R453. [DOI] [PubMed] [Google Scholar]
  • 38.Grau EG, Nishioka RS, Bern HA. Effects of somatostatin and urotensin II on tilapia pituitary prolactin release and interactions between somatostatin, osmotic pressure Ca++, and adenosine 3′,5′-monophosphate in prolactin release in vitro. Endocrinol. 1982;110:910–915. [DOI] [PubMed] [Google Scholar]
  • 39.Seale AP, Mita M, Hirano T, Grau EG. Involvement of the cAMP messenger system and extracellular Ca2+ during hyposmotically-induced prolactin release in the Mozambique tilapia. Gen Comp Endocrinol. 2011;170:401–407. [DOI] [PubMed] [Google Scholar]
  • 40.Grau EG, Helms MH. The tilapia prolactin cell - twenty-five years of investigation. In: Epple A, Scanes CG, Stetson MH, eds. Progress in Comparative Endocrinology. New York, NY: Wiley-Liss; 1990:534–540. [PubMed] [Google Scholar]
  • 41.Helms LM, Grau EG, Borski RJ. Effects of osmotic pressure and somatostatin on the cAMP messenger system of the osmosensitive prolactin cell of a teleost fish, the tilapia (Oreochromis mossambicus). Gen Comp Endocrinol. 1991;83:111–117. [DOI] [PubMed] [Google Scholar]
  • 42.Specker JL, King DS, Nishioka RS, Shirahata K, Yamaguchi K, Bern HA. Isolation and partial characterization of a pair of prolactins released in vitro by the pituitary of cichlid fish, Oreochromis mossambicus. Proc Nat Acad Sci USA. 1985;82:7490–7494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yamaguchi K, Specker JL, King DS, et al. Complete amino acid sequences of a pair of fish (tilapia) prolactins, tPRL177 and tPRL188. J Biol Chem. 1988;263:9113–9121. [PubMed] [Google Scholar]
  • 44.Seale AP, Watanabe S, Grau EG. Osmoreception: perspectives on signal transduction and environmental modulation. Gen Comp Endocrinol. 2012;176:354–360. [DOI] [PubMed] [Google Scholar]
  • 45.Yamaguchi Y, Moriyama S, Lerner DT, Grau EG, Seale AP. Autocrine positive feedback regulation of prolactin release from tilapia prolactin cells and its modulation by extracellular osmolality. Endocrinol. 2016;157:3505–3516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Yamaguchi Y, Breves JP, Haws MC, Lerner DT, Grau EG, Seale AP. Acute salinity tolerance and the control of two prolactins and their receptors in the Nile tilapia (Oreochromis niloticus) and Mozambique tilapia (O mossambicus): a comparative study. Gen Comp Endocrinol. 2018;257:168–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Fiol DF, Chan SY, Kultz D. Regulation of osmotic stress transcription factor 1 (Ostf1) in tilapia (Oreochromis mossambicus) gill epithelium during salinity stress. J Exp Biol. 2006;209:3257–3265. [DOI] [PubMed] [Google Scholar]
  • 48.Fiol DF, Kultz D. Rapid hyperosmotic coinduction of two tilapia (Oreochromis mossambicus) transcription factors in gill cells. Proc Natl Acad Sci USA. 2005;102:927–932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Pierce AL, Fox BK, Davis LK, et al. Prolactin receptor, growth hormone receptor, and putative somatolactin receptor in Mozambique tilapia: tissue specific expression and differential regulation by salinity and fasting. Gen Comp Endocrinol. 2007;154:31–40. [DOI] [PubMed] [Google Scholar]
  • 50.Fiol DF, Sanmarti E, Sacchi R, Kultz D. A novel tilapia prolactin receptor is functionally distinct from its paralog. J Exp Biol. 2009;212:2007–2015. [DOI] [PubMed] [Google Scholar]
  • 51.Breves JP, Seale AP, Helms RE, Tipsmark CK, Hirano T, Grau EG. Dynamic gene expression of GH/PRL-family hormone receptors in gill and kidney during freshwater-acclimation of Mozambique tilapia. Comp Biochem Physiol. 2011;158:194–200. [DOI] [PubMed] [Google Scholar]
  • 52.Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nature Rev Genet. 2012;13:720–731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Li JJ, Biggin MD. Gene expression. Statistics requantitates the central dogma. Science. 2015;347:1066–1067. [DOI] [PubMed] [Google Scholar]
  • 54.Dohr S, Klingenhoff A, Maier H, Hrabe de Angelis M, Werner T, Schneider R. Linking disease-associated genes to regulatory networks via promoter organization. Nucleic Acids Res. 2005;33:864–872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Hermsen R, Tans S, ten Wolde PR. Transcriptional regulation by competing transcription factor modules. PLoS Comput Biol. 2006;2:e164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Augustin R, Lichtenthaler SF, Greeff M, Hansen J, Wurst W, Trumbach D. Bioinformatics identification of modules of transcription factor binding sites in Alzheimer’s disease-related genes by in silico promoter analysis and microarrays. Int J Alzheimers Dis. 2011;2011:154325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Cohen CD, Klingenhoff A, Boucherot A, et al. Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proc Natl Acad Sci USA. 2006;103:5682–5687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Zhang X, Wen H, Wang H, Ren Y, Zhao J, Li Y. RNA-Seq analysis of salinity stress-responsive transcriptome in the liver of spotted sea bass (Lateolabrax maculatus). PLoS One. 2017;12:e0173238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Nguyen TV, Jung H, Nguyen TM, Hurwood D, Mather P. Evaluation of potential candidate genes involved in salinity tolerance in striped catfish (Pangasianodon hypophthalmus) using an RNA-Seq approach. Mar Genomics. 2016;25:75–88. [DOI] [PubMed] [Google Scholar]
  • 60.Lee SY, Lee HJ, Kim YK. Comparative transcriptome profiling of selected osmotic regulatory proteins in the gill during seawater acclimation of chum salmon (Oncorhynchus keta) fry. Sci Rep. 2020;10:1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Su H, Ma D, Zhu H, Liu Z, Gao F. Transcriptomic response to three osmotic stresses in gills of hybrid tilapia (Oreochromis mossambicus female × O urolepis hornorum male). BMC Genom. 2020;21:110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Whitehead A, Roach JL, Zhang S, Galvez F. Salinity- and population-dependent genome regulatory response during osmotic acclimation in the killifish (Fundulus heteroclitus) gill. J Exp Biol. 2012;215:1293–1305. [DOI] [PubMed] [Google Scholar]
  • 63.Wong MK, Ozaki H, Suzuki Y, Iwasaki W, Takei Y. Discovery of osmotic sensitive transcription factors in fish intestine via a transcriptomic approach. BMC Genom. 2014;15:1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ferraris JD, Williams CK, Ohtaka A, Garcia-Perez A. Functional consensus for mammalian osmotic response elements. Am J Physiol. 1999;276:C667–C673. [DOI] [PubMed] [Google Scholar]
  • 65.Ruepp B, Bohren KM, Gabbay KH. Characterization of the osmotic response element of the human aldose reductase gene promoter. Proc Natl Acad Sci USA. 1996;93:8624–8629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Ferraris JD, Garcia-Perez A. Osmotically responsive genes: the mammalian osmotic response element (ORE). Amer Zool. 2001;41:734–742. [Google Scholar]
  • 67.Wang X, Kultz D. Osmolality/salinity-responsive enhancers (OSREs) control induction of osmoprotective genes in euryhaline fish. Proc Natl Acad Sci USA. 2017;114:E2729–E2738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Swennen D, Poncelet AC, Sekkali B, Rentier-Delrue F, Martial JA, Belayew A. Structure of the tilapia (Oreochromis mossambicus) prolactin I gene. DNA Cell Biol. 1992;11:673–684. [DOI] [PubMed] [Google Scholar]
  • 69.Poncelet AC, Yaron Z, Levavi-Sivan B, Martial JA, Muller M. Regulation of prolactin gene expression in fish. In: Nagabhushanan R, Thompson MF, Fingerman M, eds. Recent Advances in Marine Biotechnology. New Delhi, India: Oxford University Press; 1997:383–405. [Google Scholar]
  • 70.Nelson C, Albert VR, Elsholtz LI, Lu W, Rosenfield MG. Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science. 1988;239:1400–1405. [DOI] [PubMed] [Google Scholar]
  • 71.Argenton F, Ramoz N, Charlet N, Bernardini S, Colombo L, Bortolussi M. Mechanisms of transcriptional activation of the promoter of the rainbow trout prolactin gene by GHF1/Pit1 and glucocorticoid. Biochem Biophys Res Commun. 1996;224:57–66. [DOI] [PubMed] [Google Scholar]
  • 72.Poncelet AC, Levavi-Sivan B, Muller M, Yaron Z, Martial JA, Belayew A. The tilapia prolactin I gene: evolutionary conservation of the regulatory elements directing pituitary-specific expression. DNA Cell Biol. 1996;15:679–692. [DOI] [PubMed] [Google Scholar]
  • 73.Naylor LH, Clark EM. d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic Acids Res. 1990;18:1595–1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Streelman JT, Kocher TD. Microsatellite variation associated with prolactin expression and growth of salt-challenged tilapia. Physiol Genomics. 2002;9:1–4. [DOI] [PubMed] [Google Scholar]
  • 75.Bernstein E, Allis CD. RNA meets chromatin. Genes Dev. 2005;19:1635–1655. [DOI] [PubMed] [Google Scholar]
  • 76.Whitehead J, Pandey GK, Kanduri C. Regulation of the mammalian epigenome by long noncoding RNAs. Biochim Biophys Acta. 2009;1790:936–947. [DOI] [PubMed] [Google Scholar]
  • 77.Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904–914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999;68:821–861. [DOI] [PubMed] [Google Scholar]
  • 79.Herr W, Sturm RA, Clerc RG, et al. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 1988;2:1513–1516. [DOI] [PubMed] [Google Scholar]
  • 80.Sze JY, Zhang S, Li J, Ruvkun G. The C. elegans POU-domain transcription factor UNC-86 regulates the tph-1 tryptophan hydroxylase gene and neurite outgrowth in specific serotonergic neurons. Development. 2002;129:3901–3911. [DOI] [PubMed] [Google Scholar]
  • 81.Gerrero MR, McEvilly RJ, Turner E, et al. Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs. Proc Natl Acad Sci USA. 1993;90:10841–10845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Latchman DS. POU family transcription factors in the nervous system. J Cell Physiol. 1999;179:126–133. [DOI] [PubMed] [Google Scholar]
  • 83.Budhram-Mahadeo V, Parker M, Latchman DS. POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol Cell Biol. 1998;18:1029–1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Barry TP, Grau EG. Estradiol-17 beta and thyrotropin-releasing hormone stimulate prolactin release from the pituitary gland of a teleost fish in vitro. Gen Comp Endocrinol. 1986;62:306–314. [DOI] [PubMed] [Google Scholar]
  • 85.Weber GM, Powell JF, Park M, et al. Evidence that gonadotropin-releasing hormone (GnRH) functions as a prolactin-releasing factor in a teleost fish (Oreochromis mossambicus) and primary structures for three native GnRH molecules. J Endocrinol. 1997;155:121–132. [DOI] [PubMed] [Google Scholar]
  • 86.Seale AP, Itoh T, Moriyama S, et al. Isolation and characterization of a homologue of mammalian prolactin-releasing peptide from the tilapia brain and its effect on prolactin release from the tilapia pituitary. Gen Comp Endocrinol. 2002;125:328–339. [DOI] [PubMed] [Google Scholar]
  • 87.Dawson MI, Xia Z. The retinoid X receptors and their ligands. Biochim Biophys Acta. 2012;1821:21–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Nicoll CS, Wilson SW, Nishioka R, Bern HA. Blood and pituitary prolactin levels in tilapia (Sarotherodon mossambicus; Teleostei) from different salinities as measured by a homologous radioimmunoassay. Gen Comp Endocrinol. 1981;44:365–373. [DOI] [PubMed] [Google Scholar]
  • 89.Berta P, Hawkins JR, Sinclair AH, et al. Genetic evidence equating SRY and the testis-determining factor. Nature. 1990;348:448–450. [DOI] [PubMed] [Google Scholar]
  • 90.Daftary GS, Taylor HS. Endocrine regulation of HOX genes. Endocr Rev. 2006;27:331–355. [DOI] [PubMed] [Google Scholar]
  • 91.Brooke NM, Garcia-Fernandez J, Holland PW. The ParaHox gene cluster is an evolutionary sister of the Hox gene cluster. Nature. 1998;392:920–922. [DOI] [PubMed] [Google Scholar]
  • 92.Borski RJ, Helms LM, Richman NH 3rd, Grau EG. Cortisol rapidly reduces prolactin release and cAMP and 45Ca2+ accumulation in the cichlid fish pituitary in vitro. Proc Natl Acad Sci USA. 1991;88:2758–2762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Tipsmark CK, Strom CN, Bailey ST, Borski RJ. Leptin stimulates pituitary prolactin release through an extracellular signal-regulated kinase-dependent pathway. J Endocrinol. 2008;196:275–281. [DOI] [PubMed] [Google Scholar]
  • 94.Douros JD, Baltzegar DA, Breves JP, et al. Prolactin is a major inhibitor of hepatic Leptin A synthesis and secretion: studies utilizing a homologous Leptin A ELISA in the tilapia. Gen Comp Endocrinol. 2014;207:86–93. [DOI] [PubMed] [Google Scholar]
  • 95.Douros JD, Baltzegar DA, Reading BJ, et al. Leptin stimulates cellular glycolysis through a STAT3 dependent mechanism in Tilapia. Front Endocrinol (Lausanne). 2018;9:465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Baltzegar DA, Reading BJ, Douros JD, Borski RJ. Role for leptin in promoting glucose mobilization during acute hyperosmotic stress in teleost fishes. J Endocrinol. 2014;220:61–72. [DOI] [PubMed] [Google Scholar]
  • 97.Shepherd BS, Sakamoto T, Nishioka RS, et al. Somatotropic actions of the homologous growth hormone and prolactins in the euryhaline teleost, the tilapia, Oreochromis mossambicus. Proc Natl Acad Sci USA. 1997;94:2068–2072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Andrews S. FastQC: A Quality Control Tool for High Throughput Sequence Data. 2010. http://wwwbioinformaticsbabrahamacuk/projects/fastqc/. Accessed June 2013.
  • 99.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Broad Institute. Tilapia Genome Project. Cambridge, MA: Broad Institute; 2011. https://www.broadinstitute.org/tilapia/tilapia-genome-project. Accessed June 2013. [Google Scholar]
  • 102.Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 2011;12:323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Leng N, Dawson JA, Thomson JA, et al. EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics. 2013;29:1035–1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Durinck S, Moreau Y, Kasprzyk A, et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics. 2005;21:3439–3440. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table S1
Figure S1

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

RESOURCES